BCA Weekly Commentary 10/28/20: Covid Worries Spike


SUMMARY. Despite the growing panic in regards to case spikes and further closures we remain focused on reopening tied to vaccine availability and drug therapies such as antibody drugs from likes of Regeneron. We are more focused on the falling death rate as an indicator of concern not cases. Vaccine progress and approval of antibody therapies is expected imminently which may play a pivotal role in finally lifting state closures/restrictions. The election uncertainty is only adding to market volatility. During the week we saw a shift in polls (those not widely reported in media that have proven in 2016 most accurate) to Trump which may foreshadow a repeat of 2016. Why that is important is that will decide degree of growth in 2021.


INVESTMENT IMPACT. The spike in fear has once again presented what we deem another opportunity. We shifted assets & cash to those stocks that would benefit from a return to normalcy and reopening that we believe may occur regardless of election outcome. The market turmoil has prompted us to increase equity exposures as many stocks in our model portfolios are significantly off their 52 week highs.


Our model portfolio performance has been updated on our website as of 10/05/20.


For more insights see our website and disclosures found there at BCA. As always contact us for further explanation of how these events can affect your finances. To unsubscribe from our newsletters & website please email us with "unsubscribe" in the subject.

©2019 by Brecken Capital & Consulting. Proudly created with Wix.com